Nakaya, Aya http://orcid.org/0000-0001-8365-3987
Tanaka, Hirokazu
Yagi, Hideo
Ohta, Kensuke
Shibayama, Hirohiko
Kohara, Takae
Kanda, Junya
Shindo, Maki
Shimura, Yuji
Kosugi, Satoru
Kida, Toru
Kaneko, Hitomi
Imada, Kazunori
Karasuno, Takahiro
Matsuda, Mitsuhiro
Iida, Masato
Adachi, Yoko
Fuchida, Shin-ichi
Uoshima, Nobuhiko
Uchiyama, Hitoji
Takahashi, Ryoichi
Matsui, Toshimitsu
Wada, Katsuya
Kiyota, Miki
Shimazaki, Chihiro
Hino, Masayuki
Kuroda, Junya
Kanakura, Yuzuru
Takaori-Kondo, Akifumi
Nomura, Shosaku
Matsumura, Itaru
,
Funding for this research was provided by:
Ono Pharmaceutical
Takeda Pharmaceutical Company
Fujimoto Pharmaceutical
Celgene
Article History
Received: 13 April 2020
Revised: 15 July 2020
Accepted: 28 July 2020
First Online: 11 August 2020
Compliance with ethical standards
:
: All authors received research funding from Celgene Co., Ltd., Takeda Pharmaceutical Co., Fujimoto Pharmaceutical Co., and Ono Pharmaceutical Co. HT, HS, MH, AT, IM, KI received honoraria from Novartis Pharmaceuticals Co. JKU, HS, AT received honoraria from Janssen Pharmaceuticals. JKU, AT, IM, KI received honoraria from Bristol-Myers Squibb. JKU, HS, IM, KI received honoraria from Takeda Pharmaceutical Co. HS, KI received honoraria from Kyowa Hakko Kirin Co. HS, KI received honoraria from Chugai Pharmaceutical Co. MH, IM received honoraria from Pfizer, Inc. MH received honoraria from Merck & Co. IM received honoraria from AbbVie GK. KI received honoraria from Nippon Shinyaku, Otsuka Pharmaceutical Co, Sumitomo Dainippon Pharma, Astellas Pharma, Shire Japan. JKU, AT received research funding from Bristol-Myers Squibb. JKU received research funding from Sysmex Co. AT received research funding from COGNANO Co, Sumitomo Dainippon Pharma, Thyas Co, OHARA Pharmaceutical Co. Kinshikouraininjin. IM, YK received research funding from Chugai Pharmaceutical Co. IM received research funding from Pfizer, Inc, Eisai Co., Merck and Co., Nippon Shinyaku, Otsuka Pharmaceutical Co., Mundipharma K.K. YK received research funding from Alexion Pharma. HS received research funding from Takeda Pharmaceutical Co., Janssen Pharmaceuticals, Novartis Pharmaceuticals Co., Sanofi K.K., AstraZeneca K.K., AbbVie GK., IQVIA Services Japan K.K